Article

Comparing Nose-Throat Swabs and Nasopharyngeal Aspirates Collected From Children With Symptoms for Respiratory Virus Identification Using Real-Time Polymerase Chain Reaction

MBBS, Queensland Paediatric Infectious Diseases Laboratory, Royal Children's Hospital, Herston Queensland 4029, Australia.
PEDIATRICS (Impact Factor: 5.3). 10/2008; 122(3):e615-20. DOI: 10.1542/peds.2008-0691
Source: PubMed

ABSTRACT The objective of this study was to calculate sensitivity values for the detection of major respiratory viruses of childhood by using combined nose-throat swabs and nasopharyngeal aspirates.
Children who had symptoms and presented to a pediatric teaching hospital and had a diagnostic respiratory specimen collected were enrolled, and paired nose-throat swab and nasopharyngeal aspirate specimens were collected. Parents were asked to collect the nose-throat swab specimen in the first instance but could defer to a health care worker if unwilling. Nose-throat swab collectors were asked to rate perceived quality of collection. All nasopharyngeal aspirates were collected by a health care worker by using a standard protocol. Real-time polymerase chain reaction for 8 respiratory viruses was performed in our hospital's diagnostic laboratory.
Paired nose-throat swab/nasopharyngeal aspirate specimens were collected during 303 illnesses, with at least 1 respiratory virus identified in 186 (61%). For the major pathogens of childhood, influenza A virus and respiratory syncytial virus, collection by using the nose-throat swab had a sensitivity of 91.9% and 93.1%, respectively. A health care worker collected 219 (72%) of the nose-throat swab specimens; concordance with the nasopharyngeal aspirate was not related to health care worker collection or perceived quality of collection.
Nose-throat swab specimens, in combination with sensitive molecular testing, are a less invasive diagnostic respiratory specimen with adequate sensitivity for use in the clinic and hospital outpatient settings and large-scale community studies through parent collection. For children who present to a hospital in which an avian or pandemic strain of influenza virus is reasonably part of the differential diagnosis, nasopharyngeal aspirates or a similar collection technique (eg, nasal washes) should continue to be used.

Download full-text

Full-text

Available from: Theodorus P. Sloots, Aug 14, 2014
1 Follower
 · 
294 Views
  • Source
    • "Data analysis We performed descriptive analyses of demographic and clinical data and are presented as proportions of all participants or all paired specimens collected. Given the sensitivity and specificity of real-time PCR diagnosis, we considered a specimen from either nostril positive for any virus to represent a true-positive, similar to previous studies (Lambert et al. 2008b; Meerhoff et al. 2010). This approach means that the specificity of either specimen type for any virus will be, by definition, 100%. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Surveillance programs and research for acute respiratory infections in remote Aboriginal communities are complicated by difficulties in the storage and transport of frozen samples to urban laboratories for testing. This study assessed the sensitivity of a simple method for transporting respiratory samples from a remote setting for viral PCR compared with frozen specimens. We sampled every individual who presented to a remote Aboriginal community clinic in a non-epidemic respiratory season. Two anterior nasal swabs were collected from each participant. The left nare specimen was mailed to the laboratory via routine postal services. The right nare specimen was transported frozen. Testing for 16 viruses was undertaken using real-time multiplex PCR. A total of 140 participants were enrolled who contributed 150 study visits. Respiratory illnesses accounted for 10% of the reasons for presentation. Sixty-one viruses were identified in 50 (33.3%) presentations for 40 (28.6%) individuals; bocavirus and rhinovirus were the most common viruses identified (14.0% and 12.6% of episodes respectively). The sensitivity for any virus detected in mailed specimens was 67.2% (95%CI 55.4, 78.9) compared to 65.6% (95%CI 53.7, 77.5) for frozen specimens. The mailing of unfrozen nasal specimens from remote communities does not compromise the viability of the specimen for viral studies.
    Tropical Medicine & International Health 03/2011; 16(6):766-72. DOI:10.1111/j.1365-3156.2011.02757.x · 2.30 Impact Factor
  • Source
    • "Gene expression patterns obtained from these cells can discriminate between complex physiologic states (Aziz et al., 2007), exposures to pathogens (Ramilo et al., 2007; Simmons et al., 2007), immune modifiers (e.g., LPS) (Boldrick et al., 2002; Kobayashi et al., 2003), and environmental exposures (Dressman et al., 2007; Meadows et al., 2008; Wang et al., 2005). While current infectious disease diagnostics rely on pathogen-based detection (Chiarini et al., 2008; Lambert et al., 2008; Robinson et al., 2008), the development of reproducible means for extracting RNA from whole blood coupled with advanced statistical methods for analysis of complex data sets now allows the possibility of classifying infections based on host gene expression profiling that reveals pathogen-specific signatures of disease. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute respiratory infections (ARIs) are a common reason for seeking medical attention, and the threat of pandemic influenza will likely add to these numbers. Using human viral challenge studies with live rhinovirus, respiratory syncytial virus, and influenza A, we developed peripheral blood gene expression signatures that distinguish individuals with symptomatic ARIs from uninfected individuals with >95% accuracy. We validated this "acute respiratory viral" signature-encompassing genes with a known role in host defense against viral infections-across each viral challenge. We also validated the signature in an independently acquired data set for influenza A and classified infected individuals from healthy controls with 100% accuracy. In the same data set, we could also distinguish viral from bacterial ARIs (93% accuracy). These results demonstrate that ARIs induce changes in human peripheral blood gene expression that can be used to diagnose a viral etiology of respiratory infection and triage symptomatic individuals.
    Cell host & microbe 09/2009; 6(3):207-17. DOI:10.1016/j.chom.2009.07.006 · 12.19 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: ince the initial reports of H1N1 influenza (human swine influenza; caused by influenza A/2009/H1N1/swl) in Mexico and the United States in mid April 2009, many thousands of cases have been reported worldwide. At the time of writing, community transmission is becoming established in many areas in Australia, but the number of reported cases is likely to be an underestimate of the true incidence due to policies for testing. These guidelines provide advice to clinicians on the use of antiviral agents for H1N1 influenza 09, drawing on studies of seasonal and H5N1 (avian) influenza, emerging data on H1N1 influenza, and previous guidelines.1-4 Anti-influenza drugs are not usually available on the Pharmaceutical Benefits Scheme, but the national stockpile has been released for treatment and prophylaxis during this outbreak. Process of guideline development Because of the rapidly evolving situation, an expedited process was undertaken to develop these guidelines. One of us (A C C) reviewed the literature and formulated guidelines with substantial input from the other authors, with review by the Guidelines Committee and Executive Council of the Australasian Society for Infectious Diseases (ASID). ASID members were invited to comment; the authors responded to all comments received. The Swine Influenza Task Force of the Thoracic Society of Australia and New Zealand (TSANZ) were invited to review the guidelines. These guidelines represent a joint position statement of the ASID and the TSANZ. H1N1 influenza 09 in New York, symptoms associated with H1N1 influenza were cough (98%), subjective fever (96%), fatigue (89%), headache (82%), sore throat (82%), runny nose (82%), chills (80%), and muscle aches (80%); 95% of patients had a fever and cough and/or sore throat.7 Nausea (55%), abdominal pain (50%), diarrhoea (48%), shortness of breath (48%), and joint pain (46%) were also reported.7 A striking feature of current reports is the young age of patients; the median age of patient death in ABSTRACT • To date, there have been thousands of cases of H1N1 influenza 09 (human swine influenza) worldwide, with established community transmission in parts of Australia. • Timely diagnostic tests can enable targeted antiviral treatment early in the course of the pandemic. Rapid antigen tests will be less useful once the pandemic is established. • Recommendations for use of antiviral treatment for influenza: æ Neuraminidase inhibitors (oseltamivir and zanamivir) are the antiviral agents of choice for H1N1 influenza 09. æ In otherwise healthy children and adults with confirmed or suspected influenza, antiviral treatment is of greatest benefit when given within 48 hours of symptom onset. æ Treatment should be prioritised for patients with risk factors for severe disease, such as older people (> 65 years), pregnant women, patients with chronic disease (eg, asthma, cardiorespiratory disease, diabetes and renal failure) or immunosuppression, and young children. æ Antiviral treatment can be given to children as young as
Show more